Papers
8
Total Citations
192
H-Index
5
About
Dr. A. Descazeaud is a pioneering urological surgeon whose work centers on minimally invasive treatments for benign prostatic obstruction (BPO) and stress urinary incontinence (SUI). His major contributions include advancing waterjet ablation (Aquablation) for BPO, as demonstrated by the first French Aquablation clinical registry, which reported promising 12-month outcomes for small- to medium-size glands (63 citations). He is also a leading figure in robot-assisted artificial urinary sphincter (AUS) implantation, notably developing and refining the robot-assisted AMS-800 technique for female SUI patients—a procedure that has transformed management of intrinsic sphincter deficiency. His 2018 study on this approach (60 citations) and subsequent international multicenter work (5 citations) have established robotic AUS as a viable, less invasive alternative to open surgery. Descazeaud has further contributed to debates on robotic prostatectomy, questioning its gold-standard status (47 citations). His recent work includes a clinical trial protocol for 3D image-guided robot-assisted partial nephrectomy (5 citations). With over 190 cumulative citations, his research consistently pushes the boundaries of robotic and interventional urology, offering patients safer, more effective solutions.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Will Robotic Surgery Become the Gold Standard for Radical Prostatectomy?47 citations · 2006
- 4
- 5
- 6
- 7
- 8